Antimicrobials......Rajeshwaree...pharmD ....aminoglycosides : active against aerobic gram neegative baxcteria
mechanism of resistance is by modifying enzymes, Inhibit the protien synthesis by binding to
This presentation gives information about the antimetabolites and suicide inhibitors that we are frequently using. Their mechanism and various examples are also given
This document discusses different types of enzyme inhibition. It describes irreversible inhibitors that permanently block the active site through covalent bonding. Reversible inhibitors are further divided into competitive inhibitors that resemble the substrate and bind the active site, non-competitive inhibitors that bind elsewhere and induce conformational changes, and uncompetitive inhibitors that only bind the enzyme-substrate complex. Examples of each type are provided.
This document provides product information for Imuran (azathioprine) 50mg tablets. It warns that chronic immunosuppression with Imuran increases the risk of malignancy in humans. It describes Imuran as an immunosuppressive antimetabolite that is well absorbed orally and metabolized in the liver and erythrocytes. The main metabolites are 6-mercaptopurine and 6-thioguanine nucleotides, which can incorporate into DNA.
Reversible enzyme inhibitors can reduce or inhibit enzyme catalytic activity through reversible, non-covalent interactions with the enzyme. There are three main types of reversible inhibitors: competitive inhibitors, which compete with the substrate for the active site; uncompetitive inhibitors, which only bind to the enzyme-substrate complex; and noncompetitive inhibitors, which bind randomly to the free enzyme or enzyme-substrate complex, inhibiting both. Reversible inhibitors form equilibrium complexes with the enzyme and do not permanently modify it, allowing activity to be restored once the inhibitor is removed. Examples of reversible inhibitors discussed include sulfanilamide as a competitive inhibitor of PABA and methotrexate as a competitive inhibitor of dihydrofolate reductase.
The document discusses various immunosuppressive drugs used for organ transplantation under the following categories: selective inhibitors of cytokine production and function, immunosuppressive antimetabolites, antibodies, and corticosteroids. It then provides more detailed information on specific drugs like cyclosporine, tacrolimus, sirolimus, azathioprine, mycophenolate, muromonab-cd3, basiliximab/daclizumab, alemtuzumab, and corticosteroids including their mechanisms of action, uses, and common adverse drug reactions.
Temodal is an oral chemotherapy drug used to treat high grade brain tumors. It works by damaging and killing cancer cells to stop their growth and division. Temodal is prescribed during radiation therapy, where it is taken daily for 6 weeks, and may continue for up to 6 months after in cycles. Common side effects include nausea, vomiting, fatigue and loss of appetite. Blood counts are monitored regularly during treatment.
Maball 100mg and Maball 500mg injection - Rituximab sharonpaula
Maball 100mg injection (Rituximab) is an anticancer medicine which is used in the treatment of non-hodgkin lymphoma (nhl), blood cancer (chronic lymphocytic leukemia), rheumatoid arthritis etc @ myapplepharma
This document summarizes various alkylating agents and antimetabolites used in cancer chemotherapy. It discusses the history and mechanisms of alkylating agents such as nitrogen mustards, nitrosoureas, triazines, and platinum compounds. It provides details on specific alkylating agents including their mechanisms of action, uses, dosages, and adverse effects. The summary highlights the development of nitrogen mustard as the first alkylating agent to treat cancer and the discovery of platinum-based drugs like cisplatin through serendipity.
This presentation gives information about the antimetabolites and suicide inhibitors that we are frequently using. Their mechanism and various examples are also given
This document discusses different types of enzyme inhibition. It describes irreversible inhibitors that permanently block the active site through covalent bonding. Reversible inhibitors are further divided into competitive inhibitors that resemble the substrate and bind the active site, non-competitive inhibitors that bind elsewhere and induce conformational changes, and uncompetitive inhibitors that only bind the enzyme-substrate complex. Examples of each type are provided.
This document provides product information for Imuran (azathioprine) 50mg tablets. It warns that chronic immunosuppression with Imuran increases the risk of malignancy in humans. It describes Imuran as an immunosuppressive antimetabolite that is well absorbed orally and metabolized in the liver and erythrocytes. The main metabolites are 6-mercaptopurine and 6-thioguanine nucleotides, which can incorporate into DNA.
Reversible enzyme inhibitors can reduce or inhibit enzyme catalytic activity through reversible, non-covalent interactions with the enzyme. There are three main types of reversible inhibitors: competitive inhibitors, which compete with the substrate for the active site; uncompetitive inhibitors, which only bind to the enzyme-substrate complex; and noncompetitive inhibitors, which bind randomly to the free enzyme or enzyme-substrate complex, inhibiting both. Reversible inhibitors form equilibrium complexes with the enzyme and do not permanently modify it, allowing activity to be restored once the inhibitor is removed. Examples of reversible inhibitors discussed include sulfanilamide as a competitive inhibitor of PABA and methotrexate as a competitive inhibitor of dihydrofolate reductase.
The document discusses various immunosuppressive drugs used for organ transplantation under the following categories: selective inhibitors of cytokine production and function, immunosuppressive antimetabolites, antibodies, and corticosteroids. It then provides more detailed information on specific drugs like cyclosporine, tacrolimus, sirolimus, azathioprine, mycophenolate, muromonab-cd3, basiliximab/daclizumab, alemtuzumab, and corticosteroids including their mechanisms of action, uses, and common adverse drug reactions.
Temodal is an oral chemotherapy drug used to treat high grade brain tumors. It works by damaging and killing cancer cells to stop their growth and division. Temodal is prescribed during radiation therapy, where it is taken daily for 6 weeks, and may continue for up to 6 months after in cycles. Common side effects include nausea, vomiting, fatigue and loss of appetite. Blood counts are monitored regularly during treatment.
Maball 100mg and Maball 500mg injection - Rituximab sharonpaula
Maball 100mg injection (Rituximab) is an anticancer medicine which is used in the treatment of non-hodgkin lymphoma (nhl), blood cancer (chronic lymphocytic leukemia), rheumatoid arthritis etc @ myapplepharma
This document summarizes various alkylating agents and antimetabolites used in cancer chemotherapy. It discusses the history and mechanisms of alkylating agents such as nitrogen mustards, nitrosoureas, triazines, and platinum compounds. It provides details on specific alkylating agents including their mechanisms of action, uses, dosages, and adverse effects. The summary highlights the development of nitrogen mustard as the first alkylating agent to treat cancer and the discovery of platinum-based drugs like cisplatin through serendipity.
This document summarizes various classes of anti-cancer drugs including alkylating agents, platinum-based agents, and methylhydrazines. The most widely used alkylating agent is cyclophosphamide, an inactive prodrug metabolized into the active phosphoramide mustard. Alkylating agents work by introducing alkyl groups into DNA through covalent bonding, causing cross-linking that interferes with strand separation and cell division. Cisplatin is a commonly used platinum-based agent that forms inter-strand DNA cross-links, preferentially binding to guanine residues, and is effective against testicular and ovarian cancers but nephrotoxic. Procarbazine is a methylhydrazine prodrug that must
Immunosuppressive drugs used to treat transplant rejection include calcineurin inhibitors like cyclosporine and tacrolimus, mTOR inhibitors like sirolimus and everolimus, anti-proliferatives like azathioprine and mycophenolic acid, corticosteroids like prednisolone and hydrocortisone, and antibodies like the monoclonal anti-IL-2Rα receptor antibodies basiliximab and daclizumab or polyclonal anti-T-cell antibodies like anti-thymocyte globulin. The IL-2 receptor antagonist daclizumab is approved for use in renal, cardiac transplant, and multiple sclerosis.
This document summarizes key information about alkylating agents, a class of anticancer drugs. It describes their mechanisms of action involving alkylation of DNA, which interferes with its integrity and functions. Specific agents discussed include nitrogen mustards, nitrosoureas, triazines, and others. Toxicities involving bone marrow suppression and effects on other rapidly dividing tissues are also summarized. Pharmacological properties, indications, and dosing schedules are provided for several common alkylating agents including cyclophosphamide, ifosfamide, chlorambucil, melphalan, busulfan, dacarbazine, temozolamide, and procarbazine.
This document summarizes the interaction between the drugs amiodarone and simvastatin. It explains that amiodarone inhibits the CYP3A4 enzyme in the liver that metabolizes simvastatin, increasing simvastatin levels in the blood and risk of the muscle damage side effect rhabdomyolysis. It warns patients taking both drugs to notify their healthcare provider, as the simvastatin dose may need reducing or an alternative statin prescribed to lower cholesterol safely. Prescribers are advised not to exceed a daily 20mg dose of simvastatin for patients also taking amiodarone.
Maball 100 mg is a monoclonal antibody used to treat certain types of non-Hodgkin's lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis. It works by targeting the CD20 antigen on B-cells and inducing the immune system to attack and kill those cells. Common side effects include fever, chills, weakness, nausea, and headache. It should be administered by intravenous infusion and precautions taken for pregnant or breastfeeding women.
Antifungal drugs are used to treat and prevent fungal infections. There are several classes of antifungal drugs including polyenes, echinocandins, azoles, and others. Azole resistance can develop through mechanisms such as decreased drug concentration due to efflux pumps, target site alterations of the ERG11 gene, and bypassing of the ergosterol pathway. Amphotericin B works by binding to ergosterol in the fungal cell membrane. Ketoconazole inhibits the enzyme lanosterol 14α-demethylase. Antifungal drugs can cause side effects and are also used to treat specific fungal infections.
This document summarizes methotrexate, an antimetabolite drug used to treat various conditions like psoriasis and rheumatoid arthritis. It discusses methotrexate's structure, mechanism of action, administration, indications, contraindications, dosing, monitoring guidelines, adverse effects and drug interactions. The summary describes methotrexate as a folic acid analogue that inhibits dihydrofolate reductase, interfering with DNA synthesis and having anti-inflammatory effects. It lists approved uses including psoriasis and potential off-label uses, and emphasizes monitoring blood work and liver biopsies when using long-term.
Revolade 75mg is mainly indicated for the treatment of patients having lower platelet levels due to chronic immune thrombocytopenia and chronic hepatitis C virus infection @ Apple Pharmaceuticals
Revolade 75mg is mainly indicated for the treatment of patients having lower platelet levels due to chronic immune thrombocytopenia and chronic hepatitis C virus infection @ Apple Pharmaceuticals
Antiviral drugs are a class of medication used specifically for treating viral infections.Like antibiotics for bacteria, specific antivirals are used for specific viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.
This document summarizes the effects of various enzymes on blood group antigens. It notes that the M and N antigens are easily destroyed by common blood bank enzymes like ficin, papain and bromelin. The S and s antigens are also degraded by these enzymes but to a lesser extent and depending on enzyme strength. Fy(a) and Fy(b) antigens are destroyed by proteolytic enzymes like ficin, papain and bromelin. In contrast, treatment with ficin and papain enhances the reactivity of I and i antigens with antibodies. Similarly, reactivity of Jk(a) and Jk(b) antigens with antibodies is generally enhanced by enzyme treatment of red blood cells.
Enzyme inhibition is explained with its kinetics, animations showing mechanism of inhibitors action, examples of inhibitors are explained in detail with Enzyme inhibited.
by Dr. N. Sivaranjani, MD
The document discusses various classes of antineoplastic agents (cancer drugs) including their mechanisms of action and clinical applications. It describes how alkylating agents like cyclophosphamide work by alkylating DNA, which can cause cross-linking and inhibit DNA synthesis and function. Antimetabolites like methotrexate inhibit key enzymes involved in DNA synthesis. The document provides examples of several alkylating agents and antimetabolites, and discusses their mechanisms of action, common uses in treating different cancer types, typical administration routes, and common side effects.
The document discusses anticancer drugs and their mechanisms and toxicity. It defines key principles of anticancer drugs, including the log-kill hypothesis and that drugs are more effective against tumors with a high growth fraction. It also describes the cell cycle that normal and cancerous cells pass through. The rest of the document provides details on the classification, mechanisms of action, and toxicity of various anticancer drugs including alkylating agents, antimetabolites, taxanes, and others. It focuses in depth on selected important drugs like cyclophosphamide, cisplatin, and methotrexate, outlining their mechanisms, uses, and adverse effects.
The document discusses various types of anticancer drugs including alkylating agents like cisplatin and cyclophosphamide, antimetabolites like methotrexate and 5-fluorouracil, and targeted drugs. It describes their mechanisms of action, toxicities, and common uses in treating cancers like breast cancer, leukemia, lymphoma, and others. The goal of cancer chemotherapy is to cure cancer when possible or induce remission, but the drugs can also be used for palliation to reduce tumor size and prolong life when the cancer is not curable.
The document discusses different types of enzyme inhibition. There are three broad categories of enzyme inhibition: reversible, irreversible, and allosteric inhibition. Reversible inhibition includes competitive, non-competitive, and uncompetitive inhibition. Competitive inhibitors bind to the enzyme's active site, preventing substrate binding. Non-competitive inhibitors bind elsewhere, altering the enzyme's shape. Uncompetitive inhibitors only bind to the enzyme-substrate complex. Irreversible inhibitors covalently bind the enzyme, permanently inactivating it. Many drugs work by competitively or non-competitively inhibiting key enzymes.
The document summarizes first-line and second-line drugs used to treat tuberculosis. It describes the mechanisms of action, resistance mechanisms, clinical uses, and adverse effects of isoniazid, rifampin, pyrazinamide, ethambutol, and streptomycin as first-line agents. It then discusses second-line drugs used to treat multi-drug resistant tuberculosis, including ethionamide, capreomycin, cycloserine, aminosalicylic acid, fluoroquinolones, linezolides, and rifabutin.
This document summarizes anti-tubercular and anti-leprotic drugs. It discusses the classification, mechanism of action, pharmacokinetics, resistance, and adverse effects of first and second-line anti-tubercular drugs like isoniazid, rifampicin, pyrazinamide, ethambutol, and streptomycin. It also discusses anti-leprotic drugs like dapsone, clofazimine, rifampicin, and others. Dapsone is the oldest, cheapest, and most commonly used anti-leprotic, but can cause haemolytic anemia in G-6-PD deficient individuals.
This document discusses several classes of anti-cancer drugs including antibiotics, miscellaneous agents, and hormonal drugs. It provides details on specific drugs, their mechanisms of action which typically involve interfering with DNA or hormone pathways in cancer cells, common uses to treat various cancers, and potential adverse drug reactions. Across drug classes, common mechanisms involve inhibiting DNA and RNA synthesis, blocking hormone receptors, or inhibiting key enzymes in cancer cell growth pathways.
Beta-lactam antibiotics include penicillins, cephalosporins, carbapenems, and monobactams. They work by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins. Penicillins are further classified into natural, semisynthetic, and extended spectrum categories. Semisynthetic penicillins like amoxicillin have better oral absorption. Beta-lactamase inhibitors are often combined with antibiotics to prevent bacterial inactivation of the drug. Cephalosporins have a wider spectrum than penicillins and are classified in generations based on their antimicrobial activity. Carbapenems and monobactams also inhibit cell wall synthesis but have even broader
This document summarizes various classes of anti-cancer drugs including alkylating agents, platinum-based agents, and methylhydrazines. The most widely used alkylating agent is cyclophosphamide, an inactive prodrug metabolized into the active phosphoramide mustard. Alkylating agents work by introducing alkyl groups into DNA through covalent bonding, causing cross-linking that interferes with strand separation and cell division. Cisplatin is a commonly used platinum-based agent that forms inter-strand DNA cross-links, preferentially binding to guanine residues, and is effective against testicular and ovarian cancers but nephrotoxic. Procarbazine is a methylhydrazine prodrug that must
Immunosuppressive drugs used to treat transplant rejection include calcineurin inhibitors like cyclosporine and tacrolimus, mTOR inhibitors like sirolimus and everolimus, anti-proliferatives like azathioprine and mycophenolic acid, corticosteroids like prednisolone and hydrocortisone, and antibodies like the monoclonal anti-IL-2Rα receptor antibodies basiliximab and daclizumab or polyclonal anti-T-cell antibodies like anti-thymocyte globulin. The IL-2 receptor antagonist daclizumab is approved for use in renal, cardiac transplant, and multiple sclerosis.
This document summarizes key information about alkylating agents, a class of anticancer drugs. It describes their mechanisms of action involving alkylation of DNA, which interferes with its integrity and functions. Specific agents discussed include nitrogen mustards, nitrosoureas, triazines, and others. Toxicities involving bone marrow suppression and effects on other rapidly dividing tissues are also summarized. Pharmacological properties, indications, and dosing schedules are provided for several common alkylating agents including cyclophosphamide, ifosfamide, chlorambucil, melphalan, busulfan, dacarbazine, temozolamide, and procarbazine.
This document summarizes the interaction between the drugs amiodarone and simvastatin. It explains that amiodarone inhibits the CYP3A4 enzyme in the liver that metabolizes simvastatin, increasing simvastatin levels in the blood and risk of the muscle damage side effect rhabdomyolysis. It warns patients taking both drugs to notify their healthcare provider, as the simvastatin dose may need reducing or an alternative statin prescribed to lower cholesterol safely. Prescribers are advised not to exceed a daily 20mg dose of simvastatin for patients also taking amiodarone.
Maball 100 mg is a monoclonal antibody used to treat certain types of non-Hodgkin's lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis. It works by targeting the CD20 antigen on B-cells and inducing the immune system to attack and kill those cells. Common side effects include fever, chills, weakness, nausea, and headache. It should be administered by intravenous infusion and precautions taken for pregnant or breastfeeding women.
Antifungal drugs are used to treat and prevent fungal infections. There are several classes of antifungal drugs including polyenes, echinocandins, azoles, and others. Azole resistance can develop through mechanisms such as decreased drug concentration due to efflux pumps, target site alterations of the ERG11 gene, and bypassing of the ergosterol pathway. Amphotericin B works by binding to ergosterol in the fungal cell membrane. Ketoconazole inhibits the enzyme lanosterol 14α-demethylase. Antifungal drugs can cause side effects and are also used to treat specific fungal infections.
This document summarizes methotrexate, an antimetabolite drug used to treat various conditions like psoriasis and rheumatoid arthritis. It discusses methotrexate's structure, mechanism of action, administration, indications, contraindications, dosing, monitoring guidelines, adverse effects and drug interactions. The summary describes methotrexate as a folic acid analogue that inhibits dihydrofolate reductase, interfering with DNA synthesis and having anti-inflammatory effects. It lists approved uses including psoriasis and potential off-label uses, and emphasizes monitoring blood work and liver biopsies when using long-term.
Revolade 75mg is mainly indicated for the treatment of patients having lower platelet levels due to chronic immune thrombocytopenia and chronic hepatitis C virus infection @ Apple Pharmaceuticals
Revolade 75mg is mainly indicated for the treatment of patients having lower platelet levels due to chronic immune thrombocytopenia and chronic hepatitis C virus infection @ Apple Pharmaceuticals
Antiviral drugs are a class of medication used specifically for treating viral infections.Like antibiotics for bacteria, specific antivirals are used for specific viruses. Unlike most antibiotics, antiviral drugs do not destroy their target pathogen; instead they inhibit their development.
This document summarizes the effects of various enzymes on blood group antigens. It notes that the M and N antigens are easily destroyed by common blood bank enzymes like ficin, papain and bromelin. The S and s antigens are also degraded by these enzymes but to a lesser extent and depending on enzyme strength. Fy(a) and Fy(b) antigens are destroyed by proteolytic enzymes like ficin, papain and bromelin. In contrast, treatment with ficin and papain enhances the reactivity of I and i antigens with antibodies. Similarly, reactivity of Jk(a) and Jk(b) antigens with antibodies is generally enhanced by enzyme treatment of red blood cells.
Enzyme inhibition is explained with its kinetics, animations showing mechanism of inhibitors action, examples of inhibitors are explained in detail with Enzyme inhibited.
by Dr. N. Sivaranjani, MD
The document discusses various classes of antineoplastic agents (cancer drugs) including their mechanisms of action and clinical applications. It describes how alkylating agents like cyclophosphamide work by alkylating DNA, which can cause cross-linking and inhibit DNA synthesis and function. Antimetabolites like methotrexate inhibit key enzymes involved in DNA synthesis. The document provides examples of several alkylating agents and antimetabolites, and discusses their mechanisms of action, common uses in treating different cancer types, typical administration routes, and common side effects.
The document discusses anticancer drugs and their mechanisms and toxicity. It defines key principles of anticancer drugs, including the log-kill hypothesis and that drugs are more effective against tumors with a high growth fraction. It also describes the cell cycle that normal and cancerous cells pass through. The rest of the document provides details on the classification, mechanisms of action, and toxicity of various anticancer drugs including alkylating agents, antimetabolites, taxanes, and others. It focuses in depth on selected important drugs like cyclophosphamide, cisplatin, and methotrexate, outlining their mechanisms, uses, and adverse effects.
The document discusses various types of anticancer drugs including alkylating agents like cisplatin and cyclophosphamide, antimetabolites like methotrexate and 5-fluorouracil, and targeted drugs. It describes their mechanisms of action, toxicities, and common uses in treating cancers like breast cancer, leukemia, lymphoma, and others. The goal of cancer chemotherapy is to cure cancer when possible or induce remission, but the drugs can also be used for palliation to reduce tumor size and prolong life when the cancer is not curable.
The document discusses different types of enzyme inhibition. There are three broad categories of enzyme inhibition: reversible, irreversible, and allosteric inhibition. Reversible inhibition includes competitive, non-competitive, and uncompetitive inhibition. Competitive inhibitors bind to the enzyme's active site, preventing substrate binding. Non-competitive inhibitors bind elsewhere, altering the enzyme's shape. Uncompetitive inhibitors only bind to the enzyme-substrate complex. Irreversible inhibitors covalently bind the enzyme, permanently inactivating it. Many drugs work by competitively or non-competitively inhibiting key enzymes.
The document summarizes first-line and second-line drugs used to treat tuberculosis. It describes the mechanisms of action, resistance mechanisms, clinical uses, and adverse effects of isoniazid, rifampin, pyrazinamide, ethambutol, and streptomycin as first-line agents. It then discusses second-line drugs used to treat multi-drug resistant tuberculosis, including ethionamide, capreomycin, cycloserine, aminosalicylic acid, fluoroquinolones, linezolides, and rifabutin.
This document summarizes anti-tubercular and anti-leprotic drugs. It discusses the classification, mechanism of action, pharmacokinetics, resistance, and adverse effects of first and second-line anti-tubercular drugs like isoniazid, rifampicin, pyrazinamide, ethambutol, and streptomycin. It also discusses anti-leprotic drugs like dapsone, clofazimine, rifampicin, and others. Dapsone is the oldest, cheapest, and most commonly used anti-leprotic, but can cause haemolytic anemia in G-6-PD deficient individuals.
This document discusses several classes of anti-cancer drugs including antibiotics, miscellaneous agents, and hormonal drugs. It provides details on specific drugs, their mechanisms of action which typically involve interfering with DNA or hormone pathways in cancer cells, common uses to treat various cancers, and potential adverse drug reactions. Across drug classes, common mechanisms involve inhibiting DNA and RNA synthesis, blocking hormone receptors, or inhibiting key enzymes in cancer cell growth pathways.
Beta-lactam antibiotics include penicillins, cephalosporins, carbapenems, and monobactams. They work by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins. Penicillins are further classified into natural, semisynthetic, and extended spectrum categories. Semisynthetic penicillins like amoxicillin have better oral absorption. Beta-lactamase inhibitors are often combined with antibiotics to prevent bacterial inactivation of the drug. Cephalosporins have a wider spectrum than penicillins and are classified in generations based on their antimicrobial activity. Carbapenems and monobactams also inhibit cell wall synthesis but have even broader
The document discusses chemotherapy, describing its objectives of curing or palliating cancer, how dosages are determined, factors that affect response, classifications of chemotherapeutic agents, administration methods, responses to treatment, and common side effects like bone marrow suppression, digestive issues, nausea and vomiting. It also covers strategies to manage side effects like growth factors and antiemetics.
Tamoxifen is an anti-estrogen drug used to treat breast cancer. It works by competitively binding to estrogen receptors in cells, inhibiting estrogen's ability to stimulate cancer growth. Tamoxifen decreases production of growth factors like TGF-β and IGF-1 that promote cancer cell growth. It is also used to treat other cancers driven by estrogen and can help prevent osteoporosis and heart attacks. Side effects include menstrual irregularities and vaginal bleeding. Anti-androgens block androgen receptors in prostate cancer cells and are used to treat prostate cancer. L-asparaginase treats acute lymphoblastic leukemia and lymphomas by depriving cancer cells of the amino acid asparagine
This document provides an overview of principles of systemic therapy in cancer, including chemotherapy, endocrine therapy, immunotherapy, and targeted therapy. It discusses various classes of chemotherapeutic agents and their mechanisms of action, administration methods, principles of combination chemotherapy, and parameters for evaluating treatment responses and toxicities. It also summarizes several hormonal agents used in endocrine therapy for cancers like breast and prostate cancer. Immunotherapies and targeted therapies discussed include monoclonal antibodies, tyrosine kinase inhibitors, and other small molecule inhibitors used to treat various cancers.
- Antibiotics selectively target microbial processes without harming human host cells. Proper antibiotic use and hand hygiene have improved patient outcomes.
- Many antibiotics are naturally produced by bacteria and fungi to inhibit competition. Major classes include penicillins, cephalosporins, aminoglycosides, tetracyclines, macrolides, and sulfonamides.
- Antibiotics work by inhibiting bacterial cell wall, protein, or nucleic acid synthesis. However, antibiotic resistance has emerged through various mechanisms and poses a growing challenge.
This document discusses various hormone therapies and antagonists used to treat cancers like breast cancer and prostate cancer. It describes several classes of drugs including glucocorticoids, estrogens, selective estrogen receptor modulators, aromatase inhibitors, antiandrogens, 5-α reductase inhibitors, and GnRH analogues. For each drug class or individual drug, it provides information on mechanism of action, pharmacokinetics, uses, and adverse effects. The goal of these hormone therapies is to block the effects of hormones like estrogen and androgen that can promote the growth of hormone-sensitive cancers.
This document discusses anti-tuberculosis drugs, classifying them into first-line and second-line drugs. It provides details on specific drugs, including isoniazid, ethionamide, and rifampicin. Isoniazid's mechanism of action involves forming a complex that inhibits mycolic acid synthesis. Resistance can emerge via mutations in katG or inhA genes. Ethionamide is a second-line prodrug that requires activation and inhibits mycolic acid synthesis similar to isoniazid. Second-line drugs are used when bacteria develop resistance or first-line drugs cannot be tolerated. The document discusses mechanisms of resistance, pharmacokinetics, mechanisms of action, and adverse effects of these
Increased drug safety - avoiding reactive metabolitesAwametox AB
Reactive metabolites can cause drug-induced toxicity and attrition. They are short-lived, electrophilic species formed during Phase I drug metabolism that can covalently bind to macromolecules. While defensive mechanisms usually inactivate them, high doses or individual vulnerabilities can overwhelm these defenses and cause organ or immune toxicity. Common precursors are functional groups like alkyl halides and sulfonates that undergo oxidation to form reactive species like epoxides, imines, and quinones. Understanding reactivity and how to avoid or minimize reactive metabolite formation could improve drug safety.
Antibiotics are drugs derived from microorganisms that are used to treat bacterial and fungal infections. They either kill microbes or stop their reproduction. Up to 80% of antibiotics are prescribed for minor issues like colds and bronchitis in outpatient settings. Common classes of antibiotics include beta-lactams, aminoglycosides, quinolones, sulphonamides, and macrolides. Antibiotics have different spectrums of action, biological sources, and modes of killing or inhibiting microbes.
Antibiotics classification, synergism and antagonismNaeem Tahir
The document discusses principles of antimicrobial therapy including selective toxicity of antimicrobial drugs against microorganisms. It describes factors for selecting antimicrobial agents including identifying the infecting organism and its susceptibility. It also discusses empiric therapy. The document classifies common antibiotics as bacteriostatic or bactericidal and outlines their common uses and mechanisms of action. It further discusses synergism between antibiotic combinations and examples of synergistic and antagonistic drug interactions.
5. Targeted and miscellaneous drugs for cancer.pptxHarshikaPatel6
This document discusses various targeted cancer therapies including protein kinase inhibitors, EGFR inhibitors, HER2/neu inhibitors, angiogenesis inhibitors, proteasome inhibitors, MTOR inhibitors, and biological response modifiers. It provides details on specific drugs in each class, their mechanisms of action, uses, pharmacokinetics, and adverse effects. Key drugs and classes discussed include imatinib for CML, gefitinib and erlotinib as EGFR inhibitors, trastuzumab and lapatinib as HER2/neu inhibitors, bevacizumab as an angiogenesis inhibitor, bortezomib as a proteasome inhibitor, temsirolimus and everolimus as MTOR inhibitors, and rituximab
This document summarizes various types of adverse drug effects including pharmacological toxicity, idiosyncratic reactions, drug allergies, hepatotoxicity, nephrotoxicity, drug interactions, photosensitization, and local pain and tissue injuries. It discusses the mechanisms, clinical signs, and management of these adverse effects for different drug classes in veterinary medicine. Risk factors, treatment approaches, and ways to minimize adverse reactions are also covered.
This document discusses the classification and mechanisms of action of various anti-cancer drugs. It categorizes drugs according to their cell cycle specificity, biochemical mechanism, and chemical structure. It provides examples of drugs that are cell cycle nonspecific and cell cycle specific. It also describes the mechanisms and examples of alkylating agents, antimetabolites, antimicrotubule agents, anticancer antibiotics, hormonal agents, and topoisomerase inhibitors. Common toxicities of different drug classes are mentioned.
The document discusses principles of chemotherapy, including common agents and their mechanisms of action, side effects, and clinical considerations. It covers conventional chemotherapy drugs like alkylating agents, antimetabolites, and antitumor antibiotics, as well as their uses in treating cancers and managing side effects. The goal of chemotherapy is to cure cancer through eliminating all cancer cells, achieving long-term disease control, or palliating cancer symptoms.
This document provides an overview of anticancer drugs and chemotherapy. It discusses the general approach to cancer therapy, including killing cancer cells and modifying their growth. The main modalities of cancer treatment are described as chemotherapy, surgery, and radiation. The goals of chemotherapy are cure, prolonged remission, or palliation. Common anticancer drug classes are also summarized, including their mechanisms of action, examples, and toxicities.
Similar to Antimicrobials - AMINOGLYCOSIDES, AMPHOTERICIN, CEPHALOSPORINS, CHLORAMPHENICOL, METRINIDAZOLE, NITROFURAN, QUINOLONES AND FLUOROQUINOLONES (20)
The document defines lexical conventions and functional dependencies in SQL. Lexical conventions establish rules for acceptable characters in SQL statements and string literals. Functional dependencies define relationships between attributes, where a determination of one attribute value relies on the value of another attribute. There are three types of functional dependencies: full functional dependency where an attribute depends solely on another; partial functional dependency where an attribute depends on multiple other attributes; and transitive functional dependency where an attribute depends on another attribute which itself depends on a third attribute.
Rajeshwari ....pharm D....thyroid......thyrotoxicosis.....definition, aetiology, clinical manifestations, laboratory investigations, and treatment pharmacological and non pharmacological. production of thyroid glands in thyroid hormones.
Rajeshwari pharm D .....chromatin: chromatin is a mass of genetic material......Types of chromatin
1.EUCHROMATIN
2.HETEROCHROMATIN
FUNCTIONS OF CHROMATIN: to compress the dna into compact form....flow of genetic information.
PRESENTATION ON PARKINSONISM - A DISORDER OF CENTRAL NERVOUS SYSTEM.Rajeshwari Netha
presentation on parkinsonism
contents are:
definition,
aetiology and
pathogenesis
It is defined by disturbance of motor function charectarized by expressionless faces, a stooped posture, slowness of voluntary movement, rigidity and pill rolling tremors.
power point presentation on obesity by Rajeshwaree Netha (Doctor of pharmacy).
contents included are Introduction,pathophyisiology,clinical presentation (signs and symptoms of obesity disorder) ,Treatment,goals of treatment, general approach, Pharmacological treatment, and Evaluation of therapeutic outcomes.
This document discusses dyslipidemia, which refers to abnormal levels of lipids in the blood such as elevated cholesterol, triglycerides, and low HDL. It causes by the accumulation of LDL cholesterol and leads to atherosclerosis and increased risk of heart disease. Treatment involves lifestyle modifications like diet, exercise, weight loss to lower lipid levels as well as lipid-lowering medications like statins which work by inhibiting cholesterol production in the liver. The goals of treatment are to lower LDL cholesterol and reduce risk of heart attacks and other cardiovascular events.
हिंदी वर्णमाला पीपीटी, hindi alphabet PPT presentation, hindi varnamala PPT, Hindi Varnamala pdf, हिंदी स्वर, हिंदी व्यंजन, sikhiye hindi varnmala, dr. mulla adam ali, hindi language and literature, hindi alphabet with drawing, hindi alphabet pdf, hindi varnamala for childrens, hindi language, hindi varnamala practice for kids, https://www.drmullaadamali.com
This slide is special for master students (MIBS & MIFB) in UUM. Also useful for readers who are interested in the topic of contemporary Islamic banking.
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Dr. Vinod Kumar Kanvaria
Exploiting Artificial Intelligence for Empowering Researchers and Faculty,
International FDP on Fundamentals of Research in Social Sciences
at Integral University, Lucknow, 06.06.2024
By Dr. Vinod Kumar Kanvaria
Strategies for Effective Upskilling is a presentation by Chinwendu Peace in a Your Skill Boost Masterclass organisation by the Excellence Foundation for South Sudan on 08th and 09th June 2024 from 1 PM to 3 PM on each day.
ISO/IEC 27001, ISO/IEC 42001, and GDPR: Best Practices for Implementation and...PECB
Denis is a dynamic and results-driven Chief Information Officer (CIO) with a distinguished career spanning information systems analysis and technical project management. With a proven track record of spearheading the design and delivery of cutting-edge Information Management solutions, he has consistently elevated business operations, streamlined reporting functions, and maximized process efficiency.
Certified as an ISO/IEC 27001: Information Security Management Systems (ISMS) Lead Implementer, Data Protection Officer, and Cyber Risks Analyst, Denis brings a heightened focus on data security, privacy, and cyber resilience to every endeavor.
His expertise extends across a diverse spectrum of reporting, database, and web development applications, underpinned by an exceptional grasp of data storage and virtualization technologies. His proficiency in application testing, database administration, and data cleansing ensures seamless execution of complex projects.
What sets Denis apart is his comprehensive understanding of Business and Systems Analysis technologies, honed through involvement in all phases of the Software Development Lifecycle (SDLC). From meticulous requirements gathering to precise analysis, innovative design, rigorous development, thorough testing, and successful implementation, he has consistently delivered exceptional results.
Throughout his career, he has taken on multifaceted roles, from leading technical project management teams to owning solutions that drive operational excellence. His conscientious and proactive approach is unwavering, whether he is working independently or collaboratively within a team. His ability to connect with colleagues on a personal level underscores his commitment to fostering a harmonious and productive workplace environment.
Date: May 29, 2024
Tags: Information Security, ISO/IEC 27001, ISO/IEC 42001, Artificial Intelligence, GDPR
-------------------------------------------------------------------------------
Find out more about ISO training and certification services
Training: ISO/IEC 27001 Information Security Management System - EN | PECB
ISO/IEC 42001 Artificial Intelligence Management System - EN | PECB
General Data Protection Regulation (GDPR) - Training Courses - EN | PECB
Webinars: https://pecb.com/webinars
Article: https://pecb.com/article
-------------------------------------------------------------------------------
For more information about PECB:
Website: https://pecb.com/
LinkedIn: https://www.linkedin.com/company/pecb/
Facebook: https://www.facebook.com/PECBInternational/
Slideshare: http://www.slideshare.net/PECBCERTIFICATION
Executive Directors Chat Leveraging AI for Diversity, Equity, and InclusionTechSoup
Let’s explore the intersection of technology and equity in the final session of our DEI series. Discover how AI tools, like ChatGPT, can be used to support and enhance your nonprofit's DEI initiatives. Participants will gain insights into practical AI applications and get tips for leveraging technology to advance their DEI goals.
This presentation was provided by Steph Pollock of The American Psychological Association’s Journals Program, and Damita Snow, of The American Society of Civil Engineers (ASCE), for the initial session of NISO's 2024 Training Series "DEIA in the Scholarly Landscape." Session One: 'Setting Expectations: a DEIA Primer,' was held June 6, 2024.
2. AMINOGLYCOSIDES Charectaristics [some]
AMINO
Active against areobic gram negative organisms
Mechanism of resistance is by Modifying
enzymes
Inhibit protein synthesis by binding to 30s
ribosomal subunit
Nephrotoxic
Ototoxic
13. Sulfonamide: common charectristics
SULFA
•STEVEN-Jhonson Syndrome /Skin Rash /
Solubility is low
•Urine precipitation / Use in Urinary tract
infections
•Large spectrum (gram + & gram -)
•Folic acid synthesis inhibitor / blocker
•Analogue of PABA
14. SULFONAMIDE : Major side efects
4s
Steven –Jhonsonsyndrome
Skin rash
Solubility low( causes crystalluria)
Serum albumin displaced ( causes new born
kernicterus and potentiation of other serum
albumin binders like warfarin)
15. Tetracyclines: adverse effects
People Like Going for Versatile
Trips
•Phototoxicity
•Liver failure
•GI disturbances
•Vertigo
•Teeth and Bone toxicity /
Teratogenicity